You are subscribed to FDA Press Releases for U.S. Food & Drug Administration (FDA). This information has recently been updated and is now available.
07/05/2016 11:04 AM EDT
The U.S. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease. The Absorb GT1 Bioresorbable Vascular Scaffold System (BVS), which releases the drug everolimus to limit the growth of scar tissue, is gradually absorbed by the body in approximately three years.
. |